← Back to Search

Behavioral Intervention

Migraine Self-Management Techniques for Migraine

N/A
Recruiting
Led By Mia T Minen, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Aged between 18 and 65 years
Must have had headaches for at least 1 year
Must not have
Diagnosis of Medication Overuse Headache (MOH)
Coronary heart disease, heart attack, stroke, diabetes mellitus Type 1 or II
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 2
Awards & highlights
No Placebo-Only Group

Summary

This trial will determine if a program can help people manage their migraines better.

Who is the study for?
This study is for English-speaking adults aged 18-65 with migraines, as per ICHD-3 criteria, who've had headaches for over a year and experience them 4-29 days a month. Participants must not change their preventive migraine medications during the study but can adjust acute meds if necessary. Exclusions include substance abuse, physical limitations preventing biofeedback participation, recent relaxation therapy for migraines, opioid or barbiturate use, severe depression scores (PHQ-8 >15), or certain serious health conditions.
What is being tested?
The NYU Langone Health Headache Center is testing how well people with migraines can learn to manage their condition using different methods: virtual training sessions, in-person training workshops, and a smartphone app called RELAXaHEAD. The goal is to see if these self-management techniques are practical and helpful.
What are the potential side effects?
Since this trial focuses on non-medical interventions like training programs and an app for self-managing migraines rather than drugs or medical procedures, there aren't typical side effects associated with it. However, participants may experience varying levels of effectiveness or discomfort from engaging in the program.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 65 years old.
Select...
I have been experiencing headaches for over a year.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have been diagnosed with headaches caused by overusing medication.
Select...
I have a history of heart disease, stroke, or diabetes.
Select...
I am currently using opioids or barbiturates.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 2
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 2 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Satisfaction Scores

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: In-Person Migraine Self-ManagementActive Control2 Interventions
Group II: Remote Migraine Self-ManagementActive Control2 Interventions

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,415 Previous Clinical Trials
856,032 Total Patients Enrolled
9 Trials studying Migraine
1,073 Patients Enrolled for Migraine
Mia T Minen, MDPrincipal InvestigatorNYU Langone Health
1 Previous Clinical Trials
356 Total Patients Enrolled
1 Trials studying Migraine
356 Patients Enrolled for Migraine
~23 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top